PPARGC1A and autosomal dominant polycystic kidney disease: Of note, BA also appears to promote mitochondrial biogenesis as measured by enhanced expression of PGC-1α in the ADPKD livers, while high-dose tolvaptan tended to decrease PGC-1α (Figure 9E).